Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report
Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer characterized by histological features resembling hepatocellular carcinoma. Surgical intervention remains the preferred treatment modality for eligible patients. However, the efficacy of neoadjuvant therapy and alternat...
Saved in:
Main Authors: | Linchuan Li, Dexu Zhang, Jiankang Zhu, Guangyong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496342/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary pancreatic hepatoid carcinoma: A case report
by: Shizheng Mi, et al.
Published: (2025-02-01) -
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01) -
Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report
by: Xiaoli Wang, et al.
Published: (2025-02-01) -
Stomach cancer in young people – a diagnostic and therapeutic problem
by: Konrad P. Zaręba, et al.
Published: (2019-12-01) -
Expression of CD68+ Tumor associated macrophages in relation to β-catenin in carcinoma stomach
by: Nikhil Sharma, et al.
Published: (2023-07-01)